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Abstract 
Purpose of the review: The incidence of anaphylaxis is increasing across all ages, but the 
risk of morbidity and fatality is disproportionately high in adolescents. This may, at least in 
part, be a consequence of a constellation of potentially-modifiable psychosocial factors that 
tend to manifest during adolescence. This paper highlights the shortcomings in and barriers 
to effective management of anaphylaxis in adolescents and proposes an integrated tripartite 
framework that may help promote successful management. 
Recent findings: Existing mainstay anaphylaxis self-management approaches – comprising 
of careful avoidance of triggers, recognition of  early features indicative of anaphylaxis and 
prompt self-administration of intra-muscular adrenaline (epinephrine) – often fail in 
adolescents. Key barriers to successful management centre on the impact of the 
psychosocial environment during adolescents’ developmental transition. As a result, risk-
taking, poor judgement of actions during reactions, and non-compliance to management 
instructions are common. 
Summary: To be successful, anaphylaxis management strategies require more multi-
dimensional approaches among adolescents. We propose a tripartite management 
framework that emphasises integration of the following components: (1) better 
understanding of adolescence; (2) incorporation of the constituents of adolescents’ social 
networks; and (3) adolescent-tailored healthcare perspectives. This theoretical framework 
now requires translation into an intervention, feasibility and pilot testing, and formal 
evaluation through randomised controlled trials. 
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Introduction 
Anaphylaxis can be defined as “a serious life-threatening generalised or systemic 
hypersensitivity reaction” [1,2,3,4**], rapid in onset, presenting with a constellation of 
features, and can be fatal in some cases [1,2,3,4**]. There are presently no reliable global 
estimates of the incidence, prevalence, morbidity, and mortality due to anaphylaxis, this in 
part being explained by variations in definition, under-recognition, under-diagnosis and 
under-coding in clinical practice [1]. However, across Europe, the population-based 
incidence rate of anaphylaxis ranges between 1.5 to 7.9 per 100 000 person-years, whereas 
the lifetime prevalence stands at about 0.3% [5]. In the United States (US), the incidence 
rate has been estimated at 50 per 100 000 person-years with a point prevalence of about 
1.6% [6,7*]. Whilst ingested foods are the most common triggers of anaphylaxis in children 
and adolescents, medications and inset stings are the most common triggers in middle-aged 
and elderly adults [1,5,6,7*]. 
The incidence of anaphylaxis appears to be increasing over time [5]. In the United Kingdom 
(UK), the age-standardised incidence rate increased from 6.7 in 2001 to 7.9 in 2005 per 100 
000 person-years while the prevalence increased from 50 to 76 per 100 000 population 
during the same period; prescription for adrenaline auto-injectors (epinephrine) increased by 
97% over the same period [8]. Similarly, between 1990 and 2000 the incidence rate 
increased from 47 to 59 per 100 000 persons in the US [6]. Although from a public health 
perspective, anaphylaxis remains an uncommon cause of death, given the increasing 
disease burden, healthcare utilisation and the fact that potentially avoidable deaths often 
occur in young people, the development of strategies for prevention of recurrence, 
management, and avoidance of fatalities has emerged as a priority area for health systems 
in many parts of the world [1,2,3,4**].  
Disproportionately, the morbidity and fatality from anaphylaxis are greater in adolescents 
than in other age groups [9,10-13,14,15,16,17]. Adolescence represents a time of great 
transition in the life of the young person, with rapid occurrence of physical, cognitive, 
psychological, and social developments [10,11,13,16,17]. There is therefore an unavoidable 
shift from dependence to independence as transfer of responsibility takes place from parents 
to the young person [10,11,13,16,17]. Socialisation increases, with an increasing influence 
from peers, which sometimes can be negative, resulting in impaired decision-making and 
risk-taking. Risk-taking is common among adolescents with food allergy – even those with 
previous food-triggered anaphylaxis – such that they sometimes eat foods that may contain 
allergens to which they are known to be sensitive. Furthermore, they may on occasions also 
fail to: seek help when experiencing reactions; recognise symptoms of anaphylaxis; carry 
their adrenaline auto-injector; and inform their peers that they are at risk of anaphylaxis 
and/or what to do if a reaction occurs [9,10-13,14,15,16,17]. Given this constellation of – 
potentially modifiable – psychosocial factors, tailoring of services in young people is crucial 
to effective management. In this paper we describe existing anaphylaxis management 
strategies, highlight key barriers to successful management in adolescents, suggest a 
theoretical framework to improve management in adolescents, and finally recommend key 
steps for policy, practice, and in particular future research to promote improved outcomes in 
adolescents at risk of anaphylaxis. 
Existing management approaches to anaphylaxis 
Effective management of anaphylaxis must include both acute/emergency treatment and 
longer-term considerations [1,2,3,4**,18,19]. Acute anaphylaxis management focuses on 
aborting reactions and providing essential life-supporting measures in order to prevent 
fatality, whereas long-term management centres on preventing any recurrence of 
anaphylaxis episode and minimising the risks if subsequent reactions ensue 
[1,2,3,4**,18**,19**]. While acute management of anaphylaxis focuses on biomedical 
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considerations, longer-term management needs to be much more concerned with the wider 
psycho-social dimensions of living with an unpredictable and potentially life-threatening 
condition [1,3,18-20]. International expert groups have recommended different management 
options for both acute and long-term management of anaphylaxis, as briefly described below 
[1,2,3,4**,18**,19**,20]. 
Acute management 
Deaths can occur within minutes of onset of anaphylaxis and it is difficult to predict the onset 
and severity of a reaction [1,2,3,4**, 18-20]. Therefore, in emergency situations, rapid initial 
steps are recommended to be taken immediately reactions occur. The mainstay and first-line 
treatment option for acute management of anaphylaxis is the prompt injection of adrenaline, 
preferably injected through the intramuscular route into the mid-anterolateral thigh 
[1,2,3,4**,18**,19**,20,21]. Delay in administration of adrenaline increases the risk of death 
[1,2,3,4**,18**,19**], but the risk is minimised if timely given, in appropriate doses, and 
administered through the recommended route [22]. Despite its potentially very important 
benefits in the acute management of anaphylaxis, adrenaline auto-injectors are under-
utilised, especially by adolescents [9,11,14,15]. Other recommended strategies, known as 
second- or third-line interventions for acute management of anaphylaxis, include initiating 
immediate call for help, provision of high-flow oxygen if indicated, intravenous fluid and 
cardiopulmonary resuscitations, and administration of H1-antihistamines, H2-antihistamines, 
and glucocorticoids [1,2,3,4**, 18-20]. 
Long-term management 
Long-term management of anaphylaxis constitutes the need for developing tailored self-
management plans aimed at preventing future recurrences of reactions [1,2,3,4**, 18], 
including detailed guidance on avoiding triggers, recognising reactions, preparing for 
reactions, and appropriate self-management of reactions if they occur [1-4,18**,19**]. To 
achieve these, at-risk individuals, together with their healthcare professionals, are 
recommended to develop personalised emergency action plans, carry their adrenaline auto-
injectors regularly, develop appropriate skills to use auto-injectors, manage concomitant 
diseases – in particular asthma in those with food-triggered reactions – and engage in 
regular follow-up assessments with their physician [1,2,3,4**, 18**,19**]. Accidental 
anaphylactic reactions become less common once recommended management plans are 
initiated, in particular if both clinical and psychosocial perspectives are incorporated into 
these plans [4**]. Immunotherapy has been shown to play an important role in long-term 
management of anaphylaxis triggered by venom and this approach is also yielding 
encouraging research results in those with food-triggered reactions; further work is however 
needed in relation to establishing the long-term effectiveness and safety profile of food 
immunotherapy [4**,19**,23,24,25]. 
Barriers to effective long-term management of anaphylaxis in adolescents 
Although the various stages of long-term management are well characterised, optimising this 
approach in adolescents is however challenging [9,10-13,14,15,16,17]. As described above, 
adolescents need to deal with a range of psychosocial developmental factors, which in many 
cases predispose to sub-optimal decision making and which may result in increased risk of 
reaction, near fatal episodes and fatal reactions, although it must be emphasised that the 
latter outcome remains very uncommon [9,10-13,14,15,16,17]. Key recurring themes from 
previous studies investigating the barriers to successful management of anaphylaxis among 
adolescents include: not being adequately prepared (e.g. adrenaline auto-injector not 
carried, asthma poorly controlled, insufficient knowledge of risky situations, and inability to 
identify potential sources of reactions); involvement in situations that lead to risk-taking (e.g. 
anxiety and fear of embarrassment and social isolation from peers, inconvenience or 
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forgetfulness in carrying adrenaline auto-injector, and not checking food labels when eating 
out); not taking appropriate help-seeking behaviour when faced with a suspected reaction; 
and not self-administering adrenaline even if available [9,10-13,14,15,16,17,26,27*].  
In a Scottish qualitative study of 26 adolescents and 28 parents, the main barriers to 
managing anaphylaxis in adolescents were failure to recognise reactions, uncertainty about 
adrenaline administration techniques and appropriate timing of administration, and fear of 
using adrenaline auto-injector [14].  In the US [11] and UK [16], only two-thirds of 
adolescents always carry their auto-injectors [10], and only a fifth had ever used these; only 
40% took steps to avoid the foods which they were allergic to [12]; all these representing 
risk-taking behaviours that may lead to reactions and poor outcomes in those experiencing 
anaphylaxis. In another Scottish study, some adolescents perceived their anaphylaxis as ‘no 
big deal’; this was particularly the case in those who could not recall a reaction as this 
happened in early childhood [13]. Risk-taking appears to vary according to the immediate 
social circumstances adolescents face. For instance, adolescents appear to be more likely to 
carry their auto-injectors when traveling or in the restaurant and less likely during sports 
activities or when wearing tight clothes [11]. Frequent carriage of auto-injectors however 
does not always translate to usage during reactions [9,11,14,15]. 
Strategies for improving management of anaphylaxis in adolescents 
 
Given the barriers noted above that inhibit successful self-management of anaphylaxis 
among adolescents, most of which relate primarily to features of the psychosocial impact of 
adolescents’ developmental transition, we suggest that a multidimensional management 
approach needs to be developed.  This should be tailored to the needs of adolescents, with 
a particular focus on tackling the known barriers to effective self-care. One such tripartite 
management approach is illustrated in Figure 1, which emerged through integration of our 
previous anaphylaxis systematic reviews and series of qualitative studies 
[4**,5,13,14,16,17,19**].  The model suggests that successful management can be achieved 
through recognising the various avenues of barriers (namely: (1) challenges of adolescents’ 
developmental transition; (2) shortcomings of current management strategies among 
adolescents; and (3) challenges of adolescents’ social networks) and then integrating these 
into clinical management strategies. The framework proposes a tripartite link between each 
of these domains, showing that, in formulating a successful and holistic management 
strategy, both for acute self-management and long-term management, the three domains 
need to be integrated. Further modelling is needed to develop this framework into a practical 
intervention, but in going forward it will, we hope, provide a firm foundation from which to 
develop effective complex interventions to support adolescents self-manage their 
anaphylaxis. 
 
According to the proposed framework, the first step to a successful anaphylaxis 
management in adolescence therefore starts with better understanding of adolescence, the 
features that characterise this developmental transition, and the respective worldviews held 
by adolescents. Such understanding presents a clear pathway to minimising the negative 
consequences of this transition [13]. Clearly, a better appreciation of this developmental 
transition and its characteristics should therefore translate into initiating both acute self-
management and long-term management approaches that integrate the social networks of 
young people and tailoring of clinical strategies to meet the needs of adolescents. As this 
transition leads to greater independence, adolescents require commensurate education on 
and training in the skills required for risk avoidance, symptom recognition, regular 
possession of their adrenaline auto-injector, and prompt use of it during a reaction. 
 
Achieving anticipated successes during this developmental transition will benefit from 
incorporating adolescents’ social networks into management strategies, given that the 
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impending independence forecloses constant parental oversight [10,11,13,16,17]. Social 
networks, such as friends/peers, teachers, or other support groups, may therefore represent 
active alternative cues to action in managing anaphylaxis, and thereby replace some of the 
oversight lost as a result of reducing parental supervision. With adequate training, 
adolescents’ social networks can serve as cues to risk avoidance, symptom recognition, 
better carriage and usage of auto-injectors, and call for help or administer adrenaline during 
emergency. A recent study from South East England showed that belonging to a patient 
support group, possessing a self-management plan, perceiving the severity of their risk, and 
less perceived barriers to management all resulted to better adherence [20]. Such groups 
are now present in some regions – for example, those run by the UK Anaphylaxis Campaign 
(http://www.anaphylaxis.org.uk/) and the US Food Allergy Research and Education 
(http://www.foodallergy.org/), which have been in the forefront of supporting those at risk or 
suffering from anaphylaxis.  Such patient support groups can prove useful in not only 
providing personalised support for the at-risk adolescents, but also serving as a means of 
informal education, training, and practical support to family members, healthcare 
professionals, teachers, and peers of adolescents on the knowledge required to successfully 
manage the risks of living with anaphylaxis [16]. 
 
Furthermore, appreciation of the features of adolescents’ developmental transition and their 
worldviews should also in due course translate into refining healthcare strategies for 
effective management. Such strategies will include: (1) developing decision support 
algorithms for symptom recognition and administration of adrenaline, possibly in electronic 
format that can be accessible via smartphone apps; (2) designing adrenaline auto-injectors 
that can be more conveniently carried - the Kaleó models being recent developments in this 
field (http://www.kaleopharma.com/); and (3) establishing helplines for real-time access to 
specialist advice - a strategy that has shown effective in improving self-rated food-specific 
quality of life of children at risk of anaphylaxis [28] . Although achieving these practical 
objectives may be challenging, unclear early warnings or threshold of symptoms that herald 
reactions may lead to poor recognition of anaphylaxis among adolescents [4**,15]. 
Therefore, from the clinical perspective, providing decision support algorithms to assess 
specific symptoms will provide prompt clue to administer adrenaline, encourage prompt 
steps to seek treatment, and call for help during reactions [4**,15]. In social engagements, 
young people prefer auto-injectors that are more convenient to carry and easy to use (like 
the emerging Kaleó models mentioned above) than the choices currently available 
[10,14,15]. 
 
Conclusions: recommendations for practice and further research 
Current anaphylaxis management strategies among adolescents have aspects of the 
approaches directed at parents of young children and those aimed at adults.  What is now 
needed is a more tailored approach based on a better appreciation of young people and the 
challenges and priorities they grapple with on a day-to-day basis.  As highlighted in this 
paper, adolescents require more tailored multidimensional and holistic management 
approaches that go beyond education about the need for regular carriage of auto-injectors, 
as these approaches in and of themselves have been shown to be inadequate. In particular, 
while frequent carriage of anaphylaxis is important, many adolescents do not use them when 
faced with reactions, even when they carry them. More fundamental barriers to successful 
anaphylaxis management in this age group therefore appear to relate to the various 
psychosocial factors encompassing adolescents’ developmental transition. We have 
highlighted that successful anaphylaxis management among adolescents will be enhanced 
by an integrated approach that incorporates better understanding of the constellation of 
features of this developmental transition into current healthcare management strategies.  
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For clinical practice, anaphylaxis management among adolescents will benefit by involving 
adolescents’ social networks, including family members, but more so their friends/peers, 
teachers, and relevant support groups given the increased independence and reduced 
parental oversight on adolescents. Well-designed education and training of each of these 
groups will be required on how to serve as cues to at-risk adolescents in avoiding potential 
triggers, on when and how to use auto-injectors, and when to call for help during the time of 
reactions. Furthermore, though challenging developing computerised decision support tools 
for symptom recognition and administration of adrenaline may be helpful. In addition, re-
designing auto-injectors that appeal to adolescents, which are convenient to carry will 
enhance better usage; at the same time, establishing helpline access to specialist advice for 
support in emergency contexts will facilitate efforts to seek quick help in times of need.  
Further research is now warranted to highlight how adolescents’ developmental trajectories 
can influence anaphylaxis management, particularly consideration of the peak and lowest 
period of risk of morbidity and fatality during adolescent developmental transition. More 
research is also needed to identify how and what educational strategies are more effective to 
influence the psychosocial environments (families, friends/peers, teachers, patient support 
groups) of adolescents in providing active cues for better prevention. In this regard, an 
assessment of the role of social media in promoting such education and training in 
enhancing the anaphylaxis management skill-sets of these groups will help in advancing this 
evidence base. Finally, the framework proposed in this paper needs to be further simulated 
in order to assess its potentials in informing the development of the clearer theoretical bases 
for initiating complex interventions [29] for anaphylaxis management among adolescents. 
 
Key Points 
 Compare to other age groups, the risk of morbidity and fatality from anaphylaxis is 
disproportionately higher in adolescents 
 Existing anaphylaxis self-management strategies often fail among adolescents 
primarily because of the influence of the psychosocial environment surrounding 
developmental transition during adolescence 
 Successful management of anaphylaxis among adolescents will therefore require 
better understanding of adolescence, the features that characterise this 
developmental transition, and the respective worldviews held by adolescents 
 We have proposed an adolescent-tailored, multidimensional, and holistic self-
management framework that emphasises incorporation of better understanding of 
adolescence into current healthcare management strategies 
 This theoretical framework now requires further simulation and translation into an 
intervention, feasibility and pilot testing, and formal evaluation through randomised 
controlled trials 
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Figure 1 Depiction of a proposed holistic framework for the management of anaphylaxis in 
adolescents that integrates the different sources of barriers to success 
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